JPH11236319A - Composition for scalp and hair - Google Patents

Composition for scalp and hair

Info

Publication number
JPH11236319A
JPH11236319A JP10126680A JP12668098A JPH11236319A JP H11236319 A JPH11236319 A JP H11236319A JP 10126680 A JP10126680 A JP 10126680A JP 12668098 A JP12668098 A JP 12668098A JP H11236319 A JPH11236319 A JP H11236319A
Authority
JP
Japan
Prior art keywords
scalp
composition
hair
hyaluronic acid
acetylated hyaluronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP10126680A
Other languages
Japanese (ja)
Inventor
Masaaki Uemura
雅明 植村
Yoshiharu Tsuji
善春 辻
Toshisuke Takeda
俊祐 武田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP10126680A priority Critical patent/JPH11236319A/en
Publication of JPH11236319A publication Critical patent/JPH11236319A/en
Withdrawn legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To prepare the subject composition useful as a cosmetic for a scalp and hair capable of safely manifesting excellent activities for preventing depilation of the hair and dandruff and itching of the scalp by including an acetylated hyaluronic acid and a circulation accelerator. SOLUTION: This composition contains (A) an acetylated hyaluronic acid [e.g. the one having 2-4 substitution degree with acetyl groups in a repeating unit of the formula (R<1> to R<4> are each H or an acetyl group bonded with an ester bond, with the proviso that two or more of the R<1> to R<4> in average are the acetyl; R<5> is H or an alkali metal atom), and (B) a circulation accelerator [e.g. nicotinic acid (benzyl ester), tocopherol nicotinate, an extract of Swertia japonica and an extract of Panax ginseng]. Preferably, the composition contains 0.001-10 wt.% component A and 0.001-5 wt.% component B based on the total of the composition.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は頭皮頭髪用組成物に
関する。さらに詳しくは優れた脱毛防止効果及びフケ・
カユミ防止効果を有する頭皮頭髪用組成物に関する。
TECHNICAL FIELD The present invention relates to a composition for scalp hair. More specifically, it has an excellent hair loss prevention effect and dandruff
The present invention relates to a scalp hair composition having a Kayumi prevention effect.

【0002】[0002]

【従来の技術】頭皮頭髪用組成物には様々な種類があ
り、様々な頭皮頭髪状態に対応した製品が毛髪化粧料、
育毛剤等として開発されている。例えば、頭皮における
フケやカユミを防止することにより脱毛を防止する製品
が開発されている。
2. Description of the Related Art There are various types of scalp hair compositions, and products corresponding to various scalp hair conditions are hair cosmetics,
It has been developed as a hair restorer and the like. For example, products have been developed that prevent hair loss by preventing dandruff and Kayumi on the scalp.

【0003】頭皮における様々なトラブルは、高齢化社
会を迎えた今日では社会的ストレスの増大も伴って増加
しつつあり、頭皮におけるトラブルに対応した頭皮頭髪
化粧料の需要は急増している。
[0003] In today's aging society, various troubles on the scalp are increasing along with an increase in social stress, and the demand for scalp hair cosmetics corresponding to troubles on the scalp is rapidly increasing.

【0004】一般に、頭部の禿や脱毛、毛の細り、頭皮
のフケやカユミ等の原因としては、毛根の皮脂腺等の器
官における男性ホルモンの活性化、過剰な皮脂分泌、過
酸化脂質の生成、毛包への血流量の低下及びストレス等
が挙げられる。
In general, baldness and alopecia of the head, thinning of hair, dandruff and kayumi of the scalp are caused by activation of androgens in organs such as sebaceous glands of hair root, excessive sebum secretion, and production of lipid peroxide. And a decrease in blood flow to the hair follicle and stress.

【0005】また、丈夫で美しい髪を育てるうえで、十
分な毛包への栄養補給が出来ない場合、細毛ややせ毛の
原因となる。また、毛包への血流量の低下は、栄養不足
や老廃物の排泄の機能の低下を招く結果となる。
[0005] In addition, when sufficient nutrition is not supplied to hair follicles for growing durable and beautiful hair, fine hair and thin hair may be caused. Also, a decrease in blood flow to the hair follicle results in a lack of nutrition and a reduced function of excreting waste products.

【0006】このような観点から、頭皮における角質層
のターンオーバーや過剰な皮脂分泌等を改善すること
は、少なくとも頭皮における血流機能の低下を改善する
ことと共に、頭皮及び頭髪のトラブルを解決する上で欠
かせないポイントとなる。
[0006] From such a point of view, improving turnover of the stratum corneum and excessive sebum secretion in the scalp solves at least a decrease in blood flow function in the scalp and solves problems in the scalp and hair. It is an indispensable point on the top.

【0007】従来の頭皮頭髪用組成物は一般に、これら
の禿や脱毛の原因と考えられる要素を取り除いたり軽減
する作用を持つ物質を配合したものである。例えば、ビ
タミンB、ビタミンE等のビタミン類、セリン、メチオ
ニン等のアミノ酸類、センブリエキス、アセチルコリン
誘導体などの血管拡張剤、紫根エキス等の抗炎症剤、エ
ストラジオール等の女性用ホルモン剤、セファランチン
などの皮膚機能亢進剤等が配合され、禿や脱毛、髪の細
りの予防および治療に用いられている。
[0007] Conventional scalp hair compositions generally contain a substance having an action of removing or reducing the factors considered to be the cause of baldness and hair loss. For example, vitamins such as vitamin B and vitamin E, amino acids such as serine and methionine, assembly extracts, vasodilators such as acetylcholine derivatives, anti-inflammatory agents such as purple root extract, hormonal agents for women such as estradiol, cepharanthin and the like It contains a skin function enhancer and the like, and is used for preventing and treating baldness, hair loss, and hair thinning.

【0008】[0008]

【発明が解決しようとする課題】しかしながら、これら
に成分を少量のみ頭皮頭髪用組成物中に配合しても十分
な効果を得ることは難しく、逆に多く配合すると使用部
分およびその周辺に深いな刺激感や発赤を伴う傾向が強
まるためその配合量には制限があり必ずしも所望の効果
が充分に得られないといった問題点があった。
However, it is difficult to obtain a sufficient effect even if only a small amount of these components is incorporated into the scalp hair composition. Since the tendency to accompany irritation and redness increases, there is a problem that the compounding amount is limited and a desired effect cannot always be sufficiently obtained.

【0009】本発明者等は上述の観点に鑑み鋭意研究を
重ねた結果、アセチル化ヒアルロン酸と特定の血行促進
剤とを組み合わせて配合することにより、優れた脱毛防
止効果と頭皮のフケ・カユミ防止効果を有しかつ安全性
にも優れる頭皮頭髪用組成物が得られることを見出し本
発明を完成するに至った。
The inventors of the present invention have conducted intensive studies in view of the above-mentioned viewpoints. As a result, the combination of acetylated hyaluronic acid and a specific blood circulation promoting agent has an excellent hair loss preventing effect and dandruff / kayumi on the scalp. The present inventors have found that a scalp hair composition having a protective effect and excellent safety can be obtained, thereby completing the present invention.

【0010】本発明は優れた脱毛防止効果と頭皮のフケ
・カユミ防止効果を有しかつ安全性にも優れる頭皮頭髪
用組成物を提供することを目的とする。
It is an object of the present invention to provide a composition for scalp hair which has an excellent effect of preventing hair loss and an effect of preventing dandruff and swelling of the scalp and is also excellent in safety.

【0011】[0011]

【課題を解決するための手段】すなわち、本発明は、ア
セチル化ヒアルロン酸と血行促進剤とを含有することを
特徴とする頭皮頭髪用組成物を提供するものである。
That is, the present invention provides a composition for scalp hair, which comprises acetylated hyaluronic acid and a blood flow promoting agent.

【0012】また、本発明は、前記アセチル化ヒアルロ
ン酸のアセチル基の置換数が、下記化学式「化2」で表
される繰り返し構造単位において平均して2〜4である
ことを特徴とする前記の頭皮頭髪用組成物を提供するも
のである。
Further, the present invention is characterized in that the acetylated hyaluronic acid has an average of 2 to 4 substitutions of an acetyl group in the repeating structural unit represented by the following chemical formula (Formula 2). And a composition for scalp hair.

【化2】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)
Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)

【0013】さらに、本発明は、前記血行促進剤が、ニ
コチン酸ベンジルエステル、ニコチン酸トコフェロー
ル、ニコチン酸、センブリエキス、ニンジンエキス、イ
チョウエキス、ビタミンE及びその誘導体、ミノキシジ
ル、塩酸カルプロニウムからなる群から選ばれた一種ま
たは二種以上であることを特徴とする前記の頭皮頭髪用
組成物を提供するものである。
Further, the present invention provides the blood circulation promoting agent, wherein the blood circulation promoting agent is selected from the group consisting of benzyl nicotinate, tocopherol nicotinate, nicotinic acid, assembly extract, carrot extract, ginkgo extract, vitamin E and its derivatives, minoxidil, and carpronium hydrochloride. One or two or more selected scalp hair compositions are provided.

【0014】また、本発明は、前記アセチル化ヒアルロ
ン酸の含有量が頭皮頭髪用組成物全量に対して0.00
1〜10重量%であることを特徴とする前記の頭皮頭髪
用組成物を提供するものである。
[0014] The present invention also relates to the present invention, wherein the content of the acetylated hyaluronic acid is 0.00% to the total amount of the scalp hair composition.
1 to 10% by weight of the composition for scalp hair.

【0015】さらに、本発明は、前記血行促進剤の含有
量が頭皮頭髪用組成物全量に対して0.001〜5重量
%であることを特徴とする前記の頭皮頭髪用組成物を提
供するものである。
Further, the present invention provides the above composition for scalp hair, wherein the content of the blood circulation promoter is 0.001 to 5% by weight based on the total amount of the composition for scalp hair. Things.

【0016】[0016]

【発明の実施の形態】以下、本発明の構成について詳述
する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The configuration of the present invention will be described below in detail.

【0017】本発明に用いるアセチル化ヒアルロン酸
は、ヒアルロン酸の水酸基を部分的にアセチル化した高
分子化合物であり、水酸基に対するアセチル化率は特に
限定されないが、下記一般式「化3」で表される繰り返
し構造単位においてアセチル基の置換数が平均して2〜
4のものが好ましい。
The acetylated hyaluronic acid used in the present invention is a high molecular compound in which the hydroxyl group of hyaluronic acid is partially acetylated. The acetylation rate for the hydroxyl group is not particularly limited, but is represented by the following general formula [Chemical Formula 3]. The number of substitution of the acetyl group in the repeating structural unit is 2 to 2 on average
Four are preferred.

【化3】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)
Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)

【0018】アセチル化ヒアルロン酸の製造方法は、例
えば、粉末状のヒアルロン酸を酢酸に分散し触媒として
無水トリフルオロ酢酸を加て反応させる方法や、酢酸に
分散しp−トルエンスルホン酸を加えさらに無水酢酸を
加えて反応させる方法、あるいは無水酢酸溶媒に懸濁さ
せ濃硫酸を加えて反応させる方法等が知られている(特
開平6−9707号公報、特開平8−53501号公報
参照)。
The method for producing acetylated hyaluronic acid includes, for example, a method in which powdery hyaluronic acid is dispersed in acetic acid and reacted by adding trifluoroacetic anhydride as a catalyst, or a method in which p-toluenesulfonic acid is dispersed in acetic acid and p-toluenesulfonic acid is added. A method of reacting by adding acetic anhydride or a method of suspending in acetic anhydride solvent and adding concentrated sulfuric acid to react is known (see JP-A-6-9707 and JP-A-8-53501).

【0019】本発明に用いるアセチル化ヒアルロン酸の
配合量は、頭皮頭髪用組成物全量に対して、通常、0.
001〜10重量%、好ましくは0.01〜5重量%で
ある。0.001重量%未満では十分な脱毛防止や頭皮
のフケ・カユミ防止効果が得られず、また、10重量%
を超えると頭皮に不快なべたつき感を与える場合があ
る。
The amount of acetylated hyaluronic acid to be used in the present invention is usually 0.1% based on the total amount of the composition for scalp and hair.
001 to 10% by weight, preferably 0.01 to 5% by weight. If the amount is less than 0.001% by weight, sufficient hair loss prevention effect and dandruff / kayumi prevention effect on the scalp cannot be obtained, and 10% by weight.
Exceeding the scalp may give an unpleasant sticky feeling.

【0020】本発明に用いる血行促進剤は、例えば、ニ
コチン酸ベンジルエステル、ニコチン酸トコフェロー
ル、ニコチン酸、センブリエキス、ニンジンエキス、イ
チョウエキス、ビタミンE及びその誘導体、ミノキシジ
ル、塩酸カルプロニウム等が挙げられ、本発明において
は、これらの一種または二種以上が好ましく用いられ
る。
The blood circulation promoter used in the present invention includes, for example, benzyl nicotinate, tocopherol nicotinate, nicotinic acid, assembly extract, carrot extract, ginkgo extract, vitamin E and its derivatives, minoxidil, carpronium hydrochloride and the like. In the present invention, one or more of these are preferably used.

【0021】本発明に用いる血行促進剤の配合量は、頭
皮頭髪用組成物全量に対して、通常、0.001〜5重
量%、好ましくは0.01〜3重量%である。0.00
1重量%未満では十分な脱毛防止や頭皮のフケ・カユミ
防止効果が得られず、また、5重量%を超えると製剤上
配合が困難になったり、頭皮に不快な刺激感を与える場
合があるので好ましくない。
The amount of the blood circulation promoter used in the present invention is usually 0.001 to 5% by weight, preferably 0.01 to 3% by weight, based on the total amount of the scalp hair composition. 0.00
If the amount is less than 1% by weight, sufficient hair loss prevention and scalp dandruff and Kayumi preventive effects cannot be obtained. If the amount is more than 5% by weight, it may be difficult to formulate the composition or may give an unpleasant irritant feeling to the scalp. It is not preferable.

【0022】本発明の頭皮頭髪用組成物は、上記した必
須成分の他に、本発明の効果を損なわない範囲で、通常
化粧料に用いられる他の成分、例えば、油分、界面活性
剤、保湿剤、増粘剤、紫外線吸収剤、酸化防止剤、防腐
剤、香料、色素、水、アルコール等の溶媒を必要に応じ
て適宜配合し目的とする剤形に応じて常法により製造す
ることができる。
The composition for scalp and hair of the present invention contains, in addition to the above-mentioned essential components, other components usually used in cosmetics, such as oils, surfactants, and moisturizers, as long as the effects of the present invention are not impaired. It can be manufactured by a conventional method according to the desired dosage form by appropriately mixing a solvent such as an agent, a thickener, an ultraviolet absorber, an antioxidant, an antiseptic, a fragrance, a pigment, water, and an alcohol as needed. it can.

【0023】本発明の頭皮頭髪用組成物とは、化粧料、
医薬品、医薬部外品として頭皮または頭髪に適用する外
用剤で、その剤型は任意であり、例えば、液状、乳液、
軟膏、クリーム、ゲル、エアゾールなど外用に適用可能
な剤型のものであればいずれでもよく、例えば、トニッ
ク、スカルプトリートメント等の形態で用いられる。
The composition for scalp hair of the present invention includes cosmetics,
Pharmaceutical, an external preparation applied to the scalp or hair as a quasi-drug, its dosage form is arbitrary, for example, liquid, emulsion,
Ointments, creams, gels, aerosols, and other dosage forms that can be applied externally may be used. For example, they are used in the form of tonics, scalp treatments, and the like.

【0024】[0024]

【実施例】次に、実施例を挙げて本発明を更に詳しく説
明するが本発明はこれらの実施例のみに限定されるもの
ではない。なお、以下の実施例において配合量は重量%
である。
Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. In addition, in the following examples, the compounding amount is% by weight.
It is.

【0025】「表1」及び「表2」に示す実施例及び比
較例について、以下の試験及び評価方法により脱毛効果
及びフケ・カユミ防止効果について検討した。その結果
を「表3」及び「表4」に示す。
With respect to the examples and comparative examples shown in Tables 1 and 2, the hair removal effect and the dandruff / kayumi prevention effect were examined by the following tests and evaluation methods. The results are shown in “Table 3” and “Table 4”.

【0026】「脱毛防止効果試験」実施例及び比較例の
試料(ローション)使用前後の洗髪による脱毛本数の変
化を測定した。被験者は男性で、比較例および実施例各
群10名とした。試験期間は6ヶ月間とし、前期の2ヶ
月間は試料無塗布の期間、後期4ヶ月間を試料塗布期間
とした。試料塗布期間には、試料を1日2回、1回につ
き2〜4mlを頭皮に塗布した。試験期間中には、1日
おきに洗髪して抜け毛を回収し、1週間分をまとめてそ
の終毛の本数を数えた。抜け毛数の評価は、試料塗布期
間の洗髪1回あたりの抜け毛本数を用い、前期最終週平
均値と後期最終週平均値を比較した。この結果を以下の
基準により判定し、+以上の被験者割合が50%以上の
場合を有効とし、その他は無効として評価した。 (判定基準) ++:抜け毛本数が70本以上減少しており著しい効果
を認めた。 +:抜け毛本数が40本以上減少しておりかなり効果を
認めた。 ±:抜け毛本数が10本以上減少しておりやや効果を認
めた。 −:抜け毛本数が10本未満の減少または抜け毛数の増
加があり効果は認められなかった。
"Test for the effect of preventing hair loss" The change in the number of hair loss due to hair washing before and after using the samples (lotions) of the examples and comparative examples was measured. The test subjects were male, and each of the comparative example and the example was 10 persons in each group. The test period was six months, the first two months were the period of no sample application, and the last four months were the sample application period. During the sample application period, 2 to 4 ml of the sample was applied to the scalp twice a day. During the test period, the hair was washed every other day to collect the hair loss, and the number of end hairs was counted for one week. The number of hair loss was evaluated by using the number of hair loss per hair washing during the sample application period, and the average value of the last week in the first half and the average value of the last week in the second half were compared. The results were judged according to the following criteria. A case where the proportion of subjects with + or more was 50% or more was evaluated as valid, and the others were evaluated as invalid. (Evaluation criteria) ++: The number of hair loss decreased by 70 or more, and a remarkable effect was recognized. +: The number of hair loss was reduced by 40 or more, and a considerable effect was recognized. ±: The number of hair loss was reduced by 10 or more, and a slight effect was recognized. -: The number of hair loss was less than 10 or the number of hair loss increased, and no effect was observed.

【0027】「フケ・カユミ防止効果試験」特にフケ・
カユミを訴える男性を対象とし、比較例および実施例各
群10名について試験終了後のフケ・カユミについて調
査し、フケ中のタンパク質量とカユミの程度によって評
価した。試料塗布期間は3ヶ月とし、この間薬剤無添加
のシャンプーで1日1回洗髪し、試料を1日2回、1回
につき2〜4mlを頭皮に塗布した。試験終了時に、被
験者より洗髪前に吸引装置により頭部フケを採取し、フ
ケ中のタンパク質量を測定してその平均値を平均フケ量
として評価した。また各被験者に対し頭皮のカユミにつ
いて調査し、その程度を以下の基準に従い判定しその平
均値で評価した。 (判定基準) 3:強いカユミがある。 2:カユミがある。 1:ややカユミがある。 0:カユミはない。
"Test for the effect of preventing dandruff and Kayumi"
A group of 10 men in each of the comparative example and the example were investigated for dandruff / kayumi after the test, and evaluated based on the amount of protein in dandruff and the degree of kayumi. The sample application period was three months. During this period, the hair was washed once a day with a shampoo containing no drug, and the sample was applied twice a day to the scalp twice a day. At the end of the test, head dandruff was collected from the subject with a suction device before washing the hair, the amount of protein in the dandruff was measured, and the average value was evaluated as the average dandruff amount. In addition, each subject was examined for scalp Kayumi, the degree was determined according to the following criteria, and the average was evaluated. (Judgment criteria) 3: There is strong Kayumi. 2: There is Kayumi. 1: There is a little Kayumi. 0: There is no Kayumi.

【0028】[0028]

【表1】 [Table 1]

【表2】 [Table 2]

【0029】「製造方法」95%エタノールに、アセチ
ル化ヒアルロン酸、血行促進剤、ジプロピレングリコー
ル、POE硬化ヒマシ油(40モル付加)、コハク酸、
香料を溶解させた。次に、精製水に色素を溶解させ、エ
タノール部に加えた後、撹拌させ透明液状のローション
を得た。
[Preparation method] In 95% ethanol, acetylated hyaluronic acid, a blood circulation promoter, dipropylene glycol, POE hydrogenated castor oil (addition of 40 mol), succinic acid,
The fragrance was dissolved. Next, the dye was dissolved in purified water, added to the ethanol part, and stirred to obtain a transparent liquid lotion.

【0030】[0030]

【表3】 [Table 3]

【表4】 [Table 4]

【0031】「表3」及び「表4」から明らかなように
本発明の実施例は脱毛防止効果に優れかつフケ・カユミ
防止効果に優れていた。
As is clear from Tables 3 and 4, the examples of the present invention were excellent in the effect of preventing hair loss and the effect of preventing dandruff and kayumi.

【0032】以下に本発明のその他の実施例を示すが、
いずれの実施例も脱毛防止、フケ・カユミ防止効果及び
安全性に優れ、安定性にも優れるものであった。
Hereinafter, other embodiments of the present invention will be described.
All of the examples were excellent in the effect of preventing hair loss, the effect of preventing dandruff and Kayumi, the safety, and the stability.

【0033】 「実施例11:ローション」 配合成分 重量% 95%エタノール 70.0 アセチル化ヒアルロン酸 10.0 ニコチン酸トコフェロール 1.0 グリセリン 1.0 POE硬化ヒマシ油(50モル付加) 0.5 リンゴ酸 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、ニコチン酸トコフェロール、グリセリン、
POE硬化ヒマシ油(50モル付加)、リンゴ酸、香料を
溶解させた。次に、精製水に色素を溶解させ、エタノー
ル部に加えた後、撹拌させ透明液状のローションを得
た。
Example 11: Lotion Ingredients Weight% 95% Ethanol 70.0 Acetylated Hyaluronic Acid 10.0 Tocopherol Nicotinate 1.0 Glycerin 1.0 POE Hardened Castor Oil (50 Mol Addition) 0.5 Apple Acid appropriate amount Flavor and dye appropriate amount Purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, and add tocopherol nicotinate, glycerin,
POE hydrogenated castor oil (50 mol added), malic acid, and fragrance were dissolved. Next, the dye was dissolved in purified water, added to the ethanol part, and stirred to obtain a transparent liquid lotion.

【0034】 「実施例12:ローション」 配合成分 重量% 95%エタノール 60.0 アセチル化ヒアルロン酸 5.0 センブリエキス 1.0 ミノキシジル 2.0 1、3ブチレングリコール 5.0 POE硬化ヒマシ油(60モル付加) 0.5 コハク酸 適量 香料および色素 適量 精製水 残分 製造方法:95%エタノールにアセチル化ヒアルロン酸
を溶解させ、センブリエキス、ミノキシジル、1、3ブ
チレングリコール、POE硬化ヒマシ油(60モル付
加)、コハク酸、香料を溶解させた。次に、精製水に色
素を溶解させ、エタノール部に加えた後、撹拌させ透明
液状のローションを得た。
Example 12: Lotion Ingredients Weight% 95% Ethanol 60.0 Acetylated Hyaluronic Acid 5.0 Assembly Extract 1.0 Minoxidil 2.0 1,3 Butylene Glycol 5.0 POE Hardened Castor Oil (60 0.5 Addition of succinic acid Appropriate amount of fragrance and dye Purified water residue Production method: Dissolve acetylated hyaluronic acid in 95% ethanol, and add assembly extract, minoxidil, 1,3 butylene glycol, POE hydrogenated castor oil (60 mol Addition), succinic acid and perfume were dissolved. Next, the dye was dissolved in purified water, added to the ethanol part, and stirred to obtain a transparent liquid lotion.

【0035】 「実施例13:乳液」 配合成分 重量% セタノール 1.8 ステアリン酸 1.1 パルミチン酸 0.5 液状ラノリン 0.5 スクワラン 2.0 モノステアリン酸グリセリル 1.8 POEソルビタンモノステアレート 0.2 塩化カルプロニウム 1.0 ビタミンEアセテート 0.5 ジプロピレングリコール 5.0 ポリエチレングリコール 2.0 アセチル化ヒアルロン酸 0.1 トリエタノールアミン 1.0 精製水 残分 製造方法:セタノールからビタミンEアセテートまでを
混合して得られた混合物と、ジプロピレングリコールか
ら精製水までを混合して得られた混合物をそれぞれ別々
に70℃に加熱溶解後、乳化機により混合乳化したの
ち、熱交換冷却にて乳液を得た。
Example 13: Emulsion Ingredients Wt% Cetanol 1.8 Stearic acid 1.1 Palmitic acid 0.5 Liquid lanolin 0.5 Squalane 2.0 Glyceryl monostearate 1.8 POE Sorbitan monostearate 0 .2 Carpronium chloride 1.0 Vitamin E acetate 0.5 Dipropylene glycol 5.0 Polyethylene glycol 2.0 Acetylated hyaluronic acid 0.1 Triethanolamine 1.0 Purified water residue Production method: From cetanol to vitamin E acetate And a mixture obtained by mixing dipropylene glycol to purified water are separately heated and melted at 70 ° C., then mixed and emulsified by an emulsifier, and then cooled by heat exchange cooling to obtain an emulsion. I got

【0036】[0036]

【発明の効果】本発明によれば、優れた脱毛防止効果を
有し、さらにはフケ・カユミ防止効果にも優れている頭
皮頭髪用組成物を提供できる。
According to the present invention, it is possible to provide a composition for scalp hair which has an excellent effect of preventing hair loss and also an excellent effect of preventing dandruff and Kayumi.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 アセチル化ヒアルロン酸と血行促進剤と
を含有することを特徴とする頭皮頭髪用組成物。
1. A composition for scalp and hair, comprising acetylated hyaluronic acid and a blood circulation promoting agent.
【請求項2】 前記アセチル化ヒアルロン酸のアセチル
基の置換数が、下記化学式「化1」で表される繰り返し
構造単位において平均して2〜4であることを特徴とす
る請求項1記載の頭皮頭髪用組成物。 【化1】 (式中、R1、R2、R3、R4は水素またはエステル結合
されたアセチル基を意味し、且つ平均して各繰り返し構
造においてR1〜R4の少なくとも2以上がアセチル基で
ある。R5は水素またはアルカリ金属原子を示す。)
2. The acetylated hyaluronic acid according to claim 1, wherein the number of substitutions of the acetyl group in the repeating structural unit represented by the following chemical formula (Chemical Formula 1) is 2 to 4 on average. Composition for scalp hair. Embedded image (Wherein, R 1 , R 2 , R 3 , and R 4 each represent hydrogen or an acetyl group bonded through an ester bond, and on average, at least two or more of R 1 to R 4 in each repeating structure are acetyl groups. R 5 represents hydrogen or an alkali metal atom.)
【請求項3】 前記血行促進剤が、ニコチン酸ベンジル
エステル、ニコチン酸トコフェロール、ニコチン酸、セ
ンブリエキス、ニンジンエキス、イチョウエキス、ビタ
ミンE及びその誘導体、ミノキシジル、塩酸カルプロニ
ウムからなる群から選ばれた一種または二種以上である
ことを特徴とする請求項1または2記載の頭皮頭髪用組
成物。
3. The blood circulation enhancer is selected from the group consisting of nicotinic acid benzyl ester, nicotinic acid tocopherol, nicotinic acid, assembly extract, carrot extract, ginkgo extract, vitamin E and its derivatives, minoxidil, and carpronium hydrochloride. 3. The composition for scalp hair according to claim 1, wherein the composition is at least two types.
【請求項4】 前記アセチル化ヒアルロン酸の含有量が
頭皮頭髪用組成物全量に対して0.001〜10重量%
であることを特徴とする請求項1、2または3記載の頭
皮頭髪用組成物。
4. The content of the acetylated hyaluronic acid is 0.001 to 10% by weight based on the total amount of the scalp hair composition.
The composition for scalp hair according to claim 1, 2, or 3.
【請求項5】 前記血行促進剤の含有量が頭皮頭髪用組
成物全量に対して0.001〜5重量%であることを特
徴とする請求項1、2、3または4記載の頭皮頭髪用組
成物。
5. The scalp head hair according to claim 1, wherein the content of the blood circulation promoting agent is 0.001 to 5% by weight based on the total amount of the scalp hair composition. Composition.
JP10126680A 1997-12-16 1998-04-21 Composition for scalp and hair Withdrawn JPH11236319A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10126680A JPH11236319A (en) 1997-12-16 1998-04-21 Composition for scalp and hair

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP36340297 1997-12-16
JP9-363402 1997-12-16
JP10126680A JPH11236319A (en) 1997-12-16 1998-04-21 Composition for scalp and hair

Publications (1)

Publication Number Publication Date
JPH11236319A true JPH11236319A (en) 1999-08-31

Family

ID=26462827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10126680A Withdrawn JPH11236319A (en) 1997-12-16 1998-04-21 Composition for scalp and hair

Country Status (1)

Country Link
JP (1) JPH11236319A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022971A1 (en) * 1999-09-27 2001-04-05 Maruha Corporation Sebum production inhibitors
EP1336402A1 (en) * 2002-02-19 2003-08-20 Pierre Fabre Dermo-Cosmetique Association of diguanosine tetraphosphate and nicotinic derivatives used for the treatment of capillary disorders, in particular the treatment of hair loss
WO2004076491A1 (en) * 2003-02-27 2004-09-10 Shiseido Co., Ltd. Medicinal composition for ophthal use containing acetylated hyaluronic acid
JP2009108038A (en) * 2007-10-10 2009-05-21 Taisho Pharmaceutical Co Ltd Minoxidil-containing liquid for external use
RU2505301C2 (en) * 2012-05-05 2014-01-27 Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук Agent for hair growth stimulation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022971A1 (en) * 1999-09-27 2001-04-05 Maruha Corporation Sebum production inhibitors
US6894034B1 (en) 1999-09-27 2005-05-17 Maruha Corporation Sebum production inhibitors
EP1336402A1 (en) * 2002-02-19 2003-08-20 Pierre Fabre Dermo-Cosmetique Association of diguanosine tetraphosphate and nicotinic derivatives used for the treatment of capillary disorders, in particular the treatment of hair loss
FR2836040A1 (en) * 2002-02-19 2003-08-22 Fabre Pierre Dermo Cosmetique ASSOCIATION OF DIGUANOSINE TETRAPHOSPHATE AND NICOTINIC DERIVATIVES, FOR THE TREATMENT OF CAPILLARY DISORDERS, IN PARTICULAR TO FIGHT THE FALL OF HAIR
WO2004076491A1 (en) * 2003-02-27 2004-09-10 Shiseido Co., Ltd. Medicinal composition for ophthal use containing acetylated hyaluronic acid
JP2004262777A (en) * 2003-02-27 2004-09-24 Shiseido Co Ltd Acetylated hyaluronic acid-containing ocular medicinal preparation
CN100348654C (en) * 2003-02-27 2007-11-14 株式会社资生堂 Medicinal composition for ophthal use containing acetylated hyaluronic acid
US7943596B2 (en) 2003-02-27 2011-05-17 Shiseido Company, Ltd. Medicinal composition for ophthal use containing acetylated hyaluronic acid
JP2009108038A (en) * 2007-10-10 2009-05-21 Taisho Pharmaceutical Co Ltd Minoxidil-containing liquid for external use
RU2505301C2 (en) * 2012-05-05 2014-01-27 Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук Agent for hair growth stimulation

Similar Documents

Publication Publication Date Title
JP2001288043A (en) Composition for scalp and hair
JP2002173449A (en) Hair-growing agent
JPH11236319A (en) Composition for scalp and hair
WO1989002731A1 (en) Hair tonic
JPH11269043A (en) Cosmetic for scalp and hair
JP2001288048A (en) Composition for scalp and hair
JPH11180833A (en) Composition for scalp and hair
JP3483984B2 (en) Cosmetics
JP2001288046A (en) Composition for scalp and hair
JP2001131031A (en) Composition for scalp and hair
JPH11180832A (en) Composition for scalp and hair
JP2001288045A (en) Composition for scalp and hair
JPH11302133A (en) Cosmetic for scalp and hair
JPH0873340A (en) Skin external preparation
JPH11255621A (en) Cosmetic for scalp and hair
JPH10273424A (en) Cosmetic for hair
JP2000044436A (en) Composition for scalp and hair treatment
JP2000026269A (en) Cosmetic
JPH10147514A (en) Cosmetic
JPH02145507A (en) Dandruff preventing cosmetic
JPH05213721A (en) External preparation for hair
JPH10273423A (en) Cosmetic for hair
JPH11322545A (en) Cosmetic for scalp and hair
JP2000026241A (en) Composition for scalp and head hair
JPH08268864A (en) Cosmetic

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20050705